Agenus Inc (AGEN)
7.41
+0.95
(+14.71%)
USD |
NASDAQ |
Apr 24, 16:00
7.45
+0.04
(+0.54%)
After-Hours: 19:51
Agenus Cash from Investing (Quarterly): 2.824M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.824M |
| September 30, 2023 | 11.55M |
| June 30, 2023 | 0.517M |
| March 31, 2023 | -11.49M |
| December 31, 2022 | -6.383M |
| September 30, 2022 | -15.64M |
| June 30, 2022 | -4.058M |
| March 31, 2022 | -7.533M |
| December 31, 2021 | -13.30M |
| September 30, 2021 | -27.38M |
| June 30, 2021 | -2.27M |
| March 31, 2021 | -0.196M |
| December 31, 2020 | -0.834M |
| September 30, 2020 | -0.873M |
| June 30, 2020 | -2.09M |
| March 31, 2020 | -0.644M |
| December 31, 2019 | -1.056M |
| September 30, 2019 | -0.839M |
| June 30, 2019 | -1.261M |
| March 31, 2019 | -1.501M |
| December 31, 2018 | -0.601M |
| September 30, 2018 | -0.819M |
| June 30, 2018 | -0.681M |
| March 31, 2018 | -1.49M |
| December 31, 2017 | 4.246M |
| Date | Value |
|---|---|
| September 30, 2017 | 9.040M |
| June 30, 2017 | -5.960M |
| March 31, 2017 | -5.262M |
| December 31, 2016 | 10.67M |
| September 30, 2016 | 24.98M |
| June 30, 2016 | 18.40M |
| March 31, 2016 | -36.46M |
| December 31, 2015 | -27.94M |
| September 30, 2015 | -1.304M |
| June 30, 2015 | -16.20M |
| March 31, 2015 | 14.21M |
| December 31, 2014 | -1.704M |
| September 30, 2014 | -0.3086M |
| June 30, 2014 | -15.14M |
| March 31, 2014 | 0.3419M |
| December 31, 2013 | -0.0665M |
| September 30, 2013 | 0.2944M |
| June 30, 2013 | -0.2141M |
| March 31, 2013 | -0.3773M |
| December 31, 2012 | -0.0024M |
| September 30, 2012 | -0.036M |
| June 30, 2012 | -0.065M |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.0011M |
| September 30, 2011 | 0.0001M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-27.38M
Minimum
Sep 2021
11.55M
Maximum
Sep 2023
-4.261M
Average
-1.261M
Median
Jun 2019
Cash from Investing (Quarterly) Benchmarks
| Protalix BioTherapeutics Inc | -0.342M |
| InfuSystems Holdings Inc | -1.044M |
| PAVmed Inc | -0.183M |
| Allogene Therapeutics Inc | 67.46M |
| Pfizer Inc | -11.00B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -40.40M |
| Cash from Financing (Quarterly) | 7.315M |
| Free Cash Flow | -234.16M |
| Free Cash Flow Per Share (Quarterly) | -2.116 |
| Free Cash Flow to Equity (Quarterly) | -40.43M |
| Free Cash Flow Yield | -176.7% |